<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9038916</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">35469050</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">9038916</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">10489</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1038/s41598-022-10489-1</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Clinical data compared between patients and controls.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Clinical data compared between patients and controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">Patients all (n = 43)</th><th align="left">Controls (n = 40)</th><th align="left" rowspan="2">p-value</th></tr><tr><th align="left">Mean ± SD</th><th align="left">Mean ± SD</th></tr></thead><tbody><tr><td align="left">Age</td><td align="left">53.5 ± 6.5</td><td align="left">52.6 ± 6.7</td><td align="left"> &lt; 0.51</td></tr><tr><td align="left">BMI</td><td align="left">28.2 ± 5</td><td align="left">26.6 ± 5</td><td align="left"> &lt; 0.14</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical data compared between patients and controls.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">Patients all (n = 43)</th><th align="left">Controls (n = 40)</th><th align="left" rowspan="2">p-value</th></tr><tr><th align="left">Mean ± SD</th><th align="left">Mean ± SD</th></tr></thead><tbody><tr><td align="left">Age</td><td align="left">53.5 ± 6.5</td><td align="left">52.6 ± 6.7</td><td align="left"> &lt; 0.51</td></tr><tr><td align="left">BMI</td><td align="left">28.2 ± 5</td><td align="left">26.6 ± 5</td><td align="left"> &lt; 0.14</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Clinical and questionnaire data compared between subgroups.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>Clinical and questionnaire data compared between subgroups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">PNS (n = 21)</th><th align="left">noPNS (n = 22)</th><th align="left" rowspan="2">p-value</th></tr><tr><th align="left">Mean ± SD/median (range)</th><th align="left">Mean ± SD/median (range)</th></tr></thead><tbody><tr><td align="left">Age</td><td align="left">53.5 ± 6.7</td><td align="left">53.4 ± 6.5</td><td align="left"> &lt; 0.9</td></tr><tr><td align="left">BMI</td><td align="left">30.9 ± 4.2</td><td align="left">25.5 ± 4.2</td><td align="left"><bold> &lt; 0.001</bold></td></tr><tr><td align="left">IENFD lower leg (fibers/mm)</td><td align="left">3.9 ± 1.5</td><td align="left">10 ± 2.6</td><td align="left"><bold> &lt; 0.001</bold></td></tr><tr><td align="left">IENFD upper thigh (fibers/mm)</td><td align="left">5.7 ± 1.5</td><td align="left">11.5 ± 2.8</td><td align="left"><bold> &lt; 0.001</bold></td></tr><tr><td align="left">Time since diagnosis (years)*</td><td align="left">5 (1–19)</td><td align="left">5 (0–14)</td><td align="left"> &lt; 0.51</td></tr><tr><td align="left">Duration of pain due to the disease (years)</td><td align="left">16.8 ± 10.8</td><td align="left">18. 8 ± 12.7</td><td align="left"> &lt; 0.71</td></tr><tr><td align="left">Number of tender points*</td><td align="left">14 (11–18)</td><td align="left">15 (7–18)</td><td align="left"> &lt; 0.23</td></tr><tr><td align="left">WPI*</td><td align="left">13.0 (10–19)</td><td align="left">15 (8–18)</td><td align="left"> &lt; 0.82</td></tr><tr><td align="left">SSS*</td><td align="left">7 (6–10)</td><td align="left">7 (5–11)</td><td align="left"> &lt; 0.87</td></tr><tr><td align="left">HbA1c (%)</td><td align="left">5.4 ± 0.3</td><td align="left">5.3 ± 0.2</td><td align="left"> &lt; 0.16</td></tr><tr><td align="left">Sural nerve SNAP (µV)</td><td align="left">22.6 ± 7.8</td><td align="left">25.1 ± 12.5</td><td align="left"> &lt; 0.45</td></tr><tr><td align="left">Sural nerve conduction velocity (m/s)</td><td align="left">48.3 ± 4.05</td><td align="left">50.4 ± 3.5</td><td align="left"> &lt; 0.09</td></tr><tr><td align="left">Serum vitamin D (µg/l)</td><td align="left">30.1 ± 14.1</td><td align="left">30.1 ± 11.1</td><td align="left"> &lt; 0.99</td></tr><tr><td align="left">Highest education level**</td><td align="left">3 (2–5)</td><td align="left">3 (2–5)</td><td align="left"> &lt; 0.13</td></tr><tr><td align="left">NPSI sum score</td><td align="left">31. 1 ± 4.2</td><td align="left">25.5 ± 4.2</td><td align="left"> &lt; 0.09</td></tr><tr><td align="left">GCPS pain intensity</td><td align="left">73.6 ± 10.8</td><td align="left">64 ± 15.1</td><td align="left"><bold> &lt; 0.02</bold></td></tr><tr><td align="left">GCPS disability due to pain*</td><td align="left">66.7 (10–83.3)</td><td align="left">53.3 (16.6–86.6)</td><td align="left"> &lt; 0.09</td></tr><tr><td align="left">Pain catastrophizing scale</td><td align="left">26.7 ± 10.1</td><td align="left">20.7 ± 10.3</td><td align="left"> &lt; 0.06</td></tr><tr><td align="left">ADS</td><td align="left">27.8 ± 11.8</td><td align="left">21.2 ± 11.4</td><td align="left"> &lt; 0.07</td></tr><tr><td align="left">FIQ</td><td align="left">51.9 ± 12</td><td align="left">42.3 ± 13.2</td><td align="left"><bold> &lt; 0.01</bold></td></tr><tr><td align="left">The O’Leary-Sant symptom index and problem index*</td><td align="left">12 (0–33)</td><td align="left">9 (1–22</td><td align="left"> &lt; 0.28</td></tr><tr><td align="left">STAI</td><td align="left">47.1 ± 11.6</td><td align="left">44.3 ± 13.3</td><td align="left"> &lt; 0.48</td></tr></tbody></table><table-wrap-foot><p><italic>ADS</italic> Allgemeine depressionskala, <italic>BMI</italic> body mass index, <italic>FIQ</italic> Fibromyalgia Impact Questionnaire, <italic>GCPS</italic> Graded Chronic Pain Scale, <italic>IENFD</italic> intraepidermal nerve fibre density, <italic>NPSI</italic> Neuropathic Pain Symptom Inventory, <italic>SNAP</italic> sensory nerve action potential, <italic>SSS</italic> Symptom Severity Score, <italic>STAI</italic> State-Trait Anxiety Inventory, <italic>WPI</italic> Widespread Pain Index.</p><p>*These data are not normally distributed, therefore the median and the range are shown here and a Mann–Whitney U test was applied.</p><p>** (1: Elementary school, 2: Primary school, 3: Secondary school, 4: High school, 5: University).</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical and questionnaire data compared between subgroups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left">PNS (n = 21)</th><th align="left">noPNS (n = 22)</th><th align="left" rowspan="2">p-value</th></tr><tr><th align="left">Mean ± SD/median (range)</th><th align="left">Mean ± SD/median (range)</th></tr></thead><tbody><tr><td align="left">Age</td><td align="left">53.5 ± 6.7</td><td align="left">53.4 ± 6.5</td><td align="left"> &lt; 0.9</td></tr><tr><td align="left">BMI</td><td align="left">30.9 ± 4.2</td><td align="left">25.5 ± 4.2</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left">IENFD lower leg (fibers/mm)</td><td align="left">3.9 ± 1.5</td><td align="left">10 ± 2.6</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left">IENFD upper thigh (fibers/mm)</td><td align="left">5.7 ± 1.5</td><td align="left">11.5 ± 2.8</td><td align="left"> &lt; 0.001</td></tr><tr><td align="left">Time since diagnosis (years)*</td><td align="left">5 (1–19)</td><td align="left">5 (0–14)</td><td align="left"> &lt; 0.51</td></tr><tr><td align="left">Duration of pain due to the disease (years)</td><td align="left">16.8 ± 10.8</td><td align="left">18. 8 ± 12.7</td><td align="left"> &lt; 0.71</td></tr><tr><td align="left">Number of tender points*</td><td align="left">14 (11–18)</td><td align="left">15 (7–18)</td><td align="left"> &lt; 0.23</td></tr><tr><td align="left">WPI*</td><td align="left">13.0 (10–19)</td><td align="left">15 (8–18)</td><td align="left"> &lt; 0.82</td></tr><tr><td align="left">SSS*</td><td align="left">7 (6–10)</td><td align="left">7 (5–11)</td><td align="left"> &lt; 0.87</td></tr><tr><td align="left">HbA1c (%)</td><td align="left">5.4 ± 0.3</td><td align="left">5.3 ± 0.2</td><td align="left"> &lt; 0.16</td></tr><tr><td align="left">Sural nerve SNAP (µV)</td><td align="left">22.6 ± 7.8</td><td align="left">25.1 ± 12.5</td><td align="left"> &lt; 0.45</td></tr><tr><td align="left">Sural nerve conduction velocity (m/s)</td><td align="left">48.3 ± 4.05</td><td align="left">50.4 ± 3.5</td><td align="left"> &lt; 0.09</td></tr><tr><td align="left">Serum vitamin D (µg/l)</td><td align="left">30.1 ± 14.1</td><td align="left">30.1 ± 11.1</td><td align="left"> &lt; 0.99</td></tr><tr><td align="left">Highest education level**</td><td align="left">3 (2–5)</td><td align="left">3 (2–5)</td><td align="left"> &lt; 0.13</td></tr><tr><td align="left">NPSI sum score</td><td align="left">31. 1 ± 4.2</td><td align="left">25.5 ± 4.2</td><td align="left"> &lt; 0.09</td></tr><tr><td align="left">GCPS pain intensity</td><td align="left">73.6 ± 10.8</td><td align="left">64 ± 15.1</td><td align="left"> &lt; 0.02</td></tr><tr><td align="left">GCPS disability due to pain*</td><td align="left">66.7 (10–83.3)</td><td align="left">53.3 (16.6–86.6)</td><td align="left"> &lt; 0.09</td></tr><tr><td align="left">Pain catastrophizing scale</td><td align="left">26.7 ± 10.1</td><td align="left">20.7 ± 10.3</td><td align="left"> &lt; 0.06</td></tr><tr><td align="left">ADS</td><td align="left">27.8 ± 11.8</td><td align="left">21.2 ± 11.4</td><td align="left"> &lt; 0.07</td></tr><tr><td align="left">FIQ</td><td align="left">51.9 ± 12</td><td align="left">42.3 ± 13.2</td><td align="left"> &lt; 0.01</td></tr><tr><td align="left">The O’Leary-Sant symptom index and problem index*</td><td align="left">12 (0–33)</td><td align="left">9 (1–22</td><td align="left"> &lt; 0.28</td></tr><tr><td align="left">STAI</td><td align="left">47.1 ± 11.6</td><td align="left">44.3 ± 13.3</td><td align="left"> &lt; 0.48</td></tr></tbody></table></div>ADS Allgemeine depressionskala, BMI body mass index, FIQ Fibromyalgia Impact Questionnaire, GCPS Graded Chronic Pain Scale, IENFD intraepidermal nerve fibre density, NPSI Neuropathic Pain Symptom Inventory, SNAP sensory nerve action potential, SSS Symptom Severity Score, STAI State-Trait Anxiety Inventory, WPI Widespread Pain Index.*These data are not normally distributed, therefore the median and the range are shown here and a Mann–Whitney U test was applied.** (1: Elementary school, 2: Primary school, 3: Secondary school, 4: High school, 5: University).</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Results of cortical volume analysis after FDR-correction.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab3"><label>Table 3</label><caption><p>Results of cortical volume analysis after FDR-correction.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Cortex parcellation</th><th align="left">p-adjusted</th><th align="left">F-value</th><th align="left">ώ-square</th></tr></thead><tbody><tr><td align="left" rowspan="10">Patients vs controls</td><td align="left">Left fusiform</td><td char="." align="char">0.04</td><td align="left">4,2</td><td align="left">0,09</td></tr><tr><td align="left">Left inferiorparietal</td><td char="." align="char">0.04</td><td align="left">3,6</td><td align="left">0,08</td></tr><tr><td align="left">Left inferiortemporal</td><td char="." align="char">0.04</td><td align="left">4,6</td><td align="left">0,1</td></tr><tr><td align="left">Left insula</td><td char="." align="char">0.04</td><td align="left">3,4</td><td align="left">0,08</td></tr><tr><td align="left">Left pericalcerine</td><td char="." align="char">0.03</td><td align="left">3,8</td><td align="left">0,09</td></tr><tr><td align="left">Right middletemporal</td><td char="." align="char">0.01</td><td align="left">5,4</td><td align="left">0,12</td></tr><tr><td align="left">Right parsopercularis</td><td char="." align="char">0.04</td><td align="left">3,2</td><td align="left">0,07</td></tr><tr><td align="left">Right superiorfrontal</td><td char="." align="char">0.03</td><td align="left">3,5</td><td align="left">0,08</td></tr><tr><td align="left">Right superiortemporal</td><td char="." align="char">0.04</td><td align="left">3,5</td><td align="left">0,08</td></tr><tr><td align="left">Right supramarginal</td><td char="." align="char">0.04</td><td align="left">4,6</td><td align="left">0,1</td></tr><tr><td align="left" rowspan="2">PNS vs NoPNS</td><td align="left">Left pericalcarine</td><td char="." align="char">0.049</td><td align="left">4.1</td><td align="left">0.06</td></tr><tr><td align="left">Right pericalcarine</td><td char="." align="char">0.03</td><td align="left">7.2</td><td align="left">0.13</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Results of cortical volume analysis after FDR-correction.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Cortex parcellation</th><th align="left">p-adjusted</th><th align="left">F-value</th><th align="left">ώ-square</th></tr></thead><tbody><tr><td align="left" rowspan="10">Patients vs controls</td><td align="left">Left fusiform</td><td char="." align="char">0.04</td><td align="left">4,2</td><td align="left">0,09</td></tr><tr><td align="left">Left inferiorparietal</td><td char="." align="char">0.04</td><td align="left">3,6</td><td align="left">0,08</td></tr><tr><td align="left">Left inferiortemporal</td><td char="." align="char">0.04</td><td align="left">4,6</td><td align="left">0,1</td></tr><tr><td align="left">Left insula</td><td char="." align="char">0.04</td><td align="left">3,4</td><td align="left">0,08</td></tr><tr><td align="left">Left pericalcerine</td><td char="." align="char">0.03</td><td align="left">3,8</td><td align="left">0,09</td></tr><tr><td align="left">Right middletemporal</td><td char="." align="char">0.01</td><td align="left">5,4</td><td align="left">0,12</td></tr><tr><td align="left">Right parsopercularis</td><td char="." align="char">0.04</td><td align="left">3,2</td><td align="left">0,07</td></tr><tr><td align="left">Right superiorfrontal</td><td char="." align="char">0.03</td><td align="left">3,5</td><td align="left">0,08</td></tr><tr><td align="left">Right superiortemporal</td><td char="." align="char">0.04</td><td align="left">3,5</td><td align="left">0,08</td></tr><tr><td align="left">Right supramarginal</td><td char="." align="char">0.04</td><td align="left">4,6</td><td align="left">0,1</td></tr><tr><td align="left" rowspan="2">PNS vs NoPNS</td><td align="left">Left pericalcarine</td><td char="." align="char">0.049</td><td align="left">4.1</td><td align="left">0.06</td></tr><tr><td align="left">Right pericalcarine</td><td char="." align="char">0.03</td><td align="left">7.2</td><td align="left">0.13</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>Tab4</table-id><table-label>Table 4</table-label><table-caption>Between group comparisons of the FA data (ROI-wise).</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab4"><label>Table 4</label><caption><p>Between group comparisons of the FA data (ROI-wise).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">White matter tract</th><th align="left">t-value</th><th align="left">p-adjusted</th><th align="left">Cohen's d</th><th align="left">Group</th><th align="left">N</th><th align="left">Mean</th><th align="left">SD</th><th align="left">SE</th></tr></thead><tbody><tr><td align="left" rowspan="28">Patients vs controls</td><td align="left" rowspan="2">Anterior corona radiata l</td><td align="left" rowspan="2">−3.292</td><td align="left" rowspan="2">0.009</td><td align="left" rowspan="2">−0.719</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.540</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.556</td><td align="left">0.003</td><td align="left">0.003</td></tr><tr><td align="left" rowspan="2">Body of corpus callosum</td><td align="left" rowspan="2">−3.705</td><td align="left" rowspan="2">0.004</td><td align="left" rowspan="2">−0.809</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.825</td><td align="left">0.003</td><td align="left">0.003</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.840</td><td align="left">0.002</td><td align="left">0.002</td></tr><tr><td align="left" rowspan="2">Cingulum 40</td><td align="left" rowspan="2">−4.384</td><td align="left" rowspan="2">0.001</td><td align="left" rowspan="2">−0.957</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.609</td><td align="left">0.006</td><td align="left">0.006</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.642</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left" rowspan="2">Cingulum 41</td><td align="left" rowspan="2">−3.456</td><td align="left" rowspan="2">0.009</td><td align="left" rowspan="2">−0.754</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.599</td><td align="left">0.006</td><td align="left">0.006</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.626</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left" rowspan="2">Fornix 44</td><td align="left" rowspan="2">−3.843</td><td align="left" rowspan="2">0.004</td><td align="left" rowspan="2">−0.839</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.573</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.595</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Genu of corpus callosum</td><td align="left" rowspan="2">−2.939</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.642</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.740</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.757</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Pontine crossing tract</td><td align="left" rowspan="2">−2.992</td><td align="left" rowspan="2">0.02</td><td align="left" rowspan="2">−0.653</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.768</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.785</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Posterior corona radiata r</td><td align="left" rowspan="2">−2.992</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.642</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.534</td><td align="left">0.02</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.551</td><td align="left">0.02</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Posterior limb of internal capsule l</td><td align="left" rowspan="2">−3.215</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.702</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.650</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.668</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Posterior thalamic radiation 34</td><td align="left" rowspan="2">−3.242</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.708</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.617</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.634</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Superior corona radiata l</td><td align="left" rowspan="2">−2.832</td><td align="left" rowspan="2">0.02</td><td align="left" rowspan="2">−0.618</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.551</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.568</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Superior corona radiata r</td><td align="left" rowspan="2">−3.129</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.683</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.540</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.556</td><td align="left">0.003</td><td align="left">0.003</td></tr><tr><td align="left" rowspan="2">Superior longitudinal fasciculus r</td><td align="left" rowspan="2">−2.773</td><td align="left" rowspan="2">0.02</td><td align="left" rowspan="2">−0.605</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.566</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.584</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Uncinate fasciculus l</td><td align="left" rowspan="2">−0.367</td><td align="left" rowspan="2">0.04</td><td align="left" rowspan="2">−0.080</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.586</td><td align="left">0.008</td><td align="left">0.008</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.590</td><td align="left">0.007</td><td align="left">0.007</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">White matter tract</th><th align="left">F-value</th><th align="left">p-adjusted</th><th align="left">ώ-square</th><th align="left">Group</th><th align="left">N</th><th align="left">Mean</th><th align="left">SD</th><th align="left">SE</th></tr></thead><tbody><tr><td align="left" rowspan="4">PNS vs noPNS</td><td align="left" rowspan="2">Posterior limb of internal capsule l</td><td align="left" rowspan="2">4.8</td><td align="left" rowspan="2">0.034</td><td align="left" rowspan="2">0.08</td><td align="left">PNS</td><td align="left">21</td><td align="left">0.658</td><td align="left">0.020</td><td align="left">0.004</td></tr><tr><td align="left">NoPNS</td><td align="left">22</td><td align="left">0.678</td><td align="left">0.029</td><td align="left">0.006</td></tr><tr><td align="left" rowspan="2">Posterior thalamic radiation 34</td><td align="left" rowspan="2">4.9</td><td align="left" rowspan="2">0.048</td><td align="left" rowspan="2">0.09</td><td align="left">PNS</td><td align="left">21</td><td align="left">0.626</td><td align="left">0.022</td><td align="left">0.005</td></tr><tr><td align="left">NoPNS</td><td align="left">22</td><td align="left">0.642</td><td align="left">0.025</td><td align="left">0.005</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Between group comparisons of the FA data (ROI-wise).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">White matter tract</th><th align="left">t-value</th><th align="left">p-adjusted</th><th align="left">Cohen's d</th><th align="left">Group</th><th align="left">N</th><th align="left">Mean</th><th align="left">SD</th><th align="left">SE</th></tr></thead><tbody><tr><td align="left" rowspan="28">Patients vs controls</td><td align="left" rowspan="2">Anterior corona radiata l</td><td align="left" rowspan="2">−3.292</td><td align="left" rowspan="2">0.009</td><td align="left" rowspan="2">−0.719</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.540</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.556</td><td align="left">0.003</td><td align="left">0.003</td></tr><tr><td align="left" rowspan="2">Body of corpus callosum</td><td align="left" rowspan="2">−3.705</td><td align="left" rowspan="2">0.004</td><td align="left" rowspan="2">−0.809</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.825</td><td align="left">0.003</td><td align="left">0.003</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.840</td><td align="left">0.002</td><td align="left">0.002</td></tr><tr><td align="left" rowspan="2">Cingulum 40</td><td align="left" rowspan="2">−4.384</td><td align="left" rowspan="2">0.001</td><td align="left" rowspan="2">−0.957</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.609</td><td align="left">0.006</td><td align="left">0.006</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.642</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left" rowspan="2">Cingulum 41</td><td align="left" rowspan="2">−3.456</td><td align="left" rowspan="2">0.009</td><td align="left" rowspan="2">−0.754</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.599</td><td align="left">0.006</td><td align="left">0.006</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.626</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left" rowspan="2">Fornix 44</td><td align="left" rowspan="2">−3.843</td><td align="left" rowspan="2">0.004</td><td align="left" rowspan="2">−0.839</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.573</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.595</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Genu of corpus callosum</td><td align="left" rowspan="2">−2.939</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.642</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.740</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.757</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Pontine crossing tract</td><td align="left" rowspan="2">−2.992</td><td align="left" rowspan="2">0.02</td><td align="left" rowspan="2">−0.653</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.768</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.785</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Posterior corona radiata r</td><td align="left" rowspan="2">−2.992</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.642</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.534</td><td align="left">0.02</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.551</td><td align="left">0.02</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Posterior limb of internal capsule l</td><td align="left" rowspan="2">−3.215</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.702</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.650</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.668</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Posterior thalamic radiation 34</td><td align="left" rowspan="2">−3.242</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.708</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.617</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.634</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Superior corona radiata l</td><td align="left" rowspan="2">−2.832</td><td align="left" rowspan="2">0.02</td><td align="left" rowspan="2">−0.618</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.551</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.568</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Superior corona radiata r</td><td align="left" rowspan="2">−3.129</td><td align="left" rowspan="2">0.01</td><td align="left" rowspan="2">−0.683</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.540</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.556</td><td align="left">0.003</td><td align="left">0.003</td></tr><tr><td align="left" rowspan="2">Superior longitudinal fasciculus r</td><td align="left" rowspan="2">−2.773</td><td align="left" rowspan="2">0.02</td><td align="left" rowspan="2">−0.605</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.566</td><td align="left">0.005</td><td align="left">0.005</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.584</td><td align="left">0.004</td><td align="left">0.004</td></tr><tr><td align="left" rowspan="2">Uncinate fasciculus l</td><td align="left" rowspan="2">−0.367</td><td align="left" rowspan="2">0.04</td><td align="left" rowspan="2">−0.080</td><td align="left">Controls</td><td align="left">41</td><td align="left">0.586</td><td align="left">0.008</td><td align="left">0.008</td></tr><tr><td align="left">Patients</td><td align="left">43</td><td align="left">0.590</td><td align="left">0.007</td><td align="left">0.007</td></tr></tbody></table></div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">White matter tract</th><th align="left">F-value</th><th align="left">p-adjusted</th><th align="left">ώ-square</th><th align="left">Group</th><th align="left">N</th><th align="left">Mean</th><th align="left">SD</th><th align="left">SE</th></tr></thead><tbody><tr><td align="left" rowspan="4">PNS vs noPNS</td><td align="left" rowspan="2">Posterior limb of internal capsule l</td><td align="left" rowspan="2">4.8</td><td align="left" rowspan="2">0.034</td><td align="left" rowspan="2">0.08</td><td align="left">PNS</td><td align="left">21</td><td align="left">0.658</td><td align="left">0.020</td><td align="left">0.004</td></tr><tr><td align="left">NoPNS</td><td align="left">22</td><td align="left">0.678</td><td align="left">0.029</td><td align="left">0.006</td></tr><tr><td align="left" rowspan="2">Posterior thalamic radiation 34</td><td align="left" rowspan="2">4.9</td><td align="left" rowspan="2">0.048</td><td align="left" rowspan="2">0.09</td><td align="left">PNS</td><td align="left">21</td><td align="left">0.626</td><td align="left">0.022</td><td align="left">0.005</td></tr><tr><td align="left">NoPNS</td><td align="left">22</td><td align="left">0.642</td><td align="left">0.025</td><td align="left">0.005</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>